Literature DB >> 2983309

Identification of the components necessary for adenovirus translational control and their utilization in cDNA expression vectors.

R J Kaufman.   

Abstract

A transient expression system was used to study the role of the adenovirus late and simian virus 40 (SV40) early mRNA leader sequences and adenovirus virus-associated (VA) RNAs in mRNA translation. Hybrid transcription units containing the adenovirus late and SV40 early promoters fused to various coding regions were introduced into monkey COS cells on plasmids containing a SV40 origin of replication. The translational efficiencies of the mRNAs produced from these plasmids were determined after alterations in the viral leader sequences or in the presence of VA RNAs provided by adenovirus infection of the transfected cells or by cotransfection with plasmids containing the VA genes. Efficient translation of mRNA with either adenovirus or SV40 leader sequences is dependent upon the presence of VA RNA. Translational stimulation by VA RNA of mRNAs containing the adenovirus tripartite leader sequences is dramatically reduced if leader exons 2 and 3 are removed or if their orientation is altered. Sequence analysis has indicated a homology between the nontranslated 5' end of SV40 early mRNA and sequences at the border of the 2nd and 3rd tripartite leader exons, which may be responsible for the increased translation of these mRNAs in the presence of VA RNA.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2983309      PMCID: PMC397111          DOI: 10.1073/pnas.82.3.689

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  25 in total

1.  Labeling deoxyribonucleic acid to high specific activity in vitro by nick translation with DNA polymerase I.

Authors:  P W Rigby; M Dieckmann; C Rhodes; P Berg
Journal:  J Mol Biol       Date:  1977-06-15       Impact factor: 5.469

2.  RNA molecular weight determinations by gel electrophoresis under denaturing conditions, a critical reexamination.

Authors:  H Lehrach; D Diamond; J M Wozney; H Boedtker
Journal:  Biochemistry       Date:  1977-10-18       Impact factor: 3.162

3.  Efficient transfer of large DNA fragments from agarose gels to diazobenzyloxymethyl-paper and rapid hybridization by using dextran sulfate.

Authors:  G M Wahl; M Stern; G R Stark
Journal:  Proc Natl Acad Sci U S A       Date:  1979-08       Impact factor: 11.205

4.  Nucleotide sequence analysis of the leader segments in a cloned copy of adenovirus 2 fiber mRNA.

Authors:  S Zain; J Sambrook; R J Roberts; W Keller; M Fried; A R Dunn
Journal:  Cell       Date:  1979-04       Impact factor: 41.582

5.  Hybridization of denatured RNA and small DNA fragments transferred to nitrocellulose.

Authors:  P S Thomas
Journal:  Proc Natl Acad Sci U S A       Date:  1980-09       Impact factor: 11.205

6.  Binding of adenovirus VA RNA to mRNA: a possible role in splicing?

Authors:  M B Mathews
Journal:  Nature       Date:  1980-06-19       Impact factor: 49.962

7.  RNA of low molecular weight in KB cells infected with adenovirus type 2.

Authors:  P R Reich; B G Forget; S M Weissman
Journal:  J Mol Biol       Date:  1966-06       Impact factor: 5.469

8.  Expression of a bacterial gene in mammalian cells.

Authors:  R C Mulligan; P Berg
Journal:  Science       Date:  1980-09-19       Impact factor: 47.728

9.  Control of adenovirus early gene expression: a class of immediate early products.

Authors:  J B Lewis; M B Mathews
Journal:  Cell       Date:  1980-08       Impact factor: 41.582

10.  Adenovirus tripartite leader sequence enhances translation of mRNAs late after infection.

Authors:  J Logan; T Shenk
Journal:  Proc Natl Acad Sci U S A       Date:  1984-06       Impact factor: 11.205

View more
  48 in total

1.  The phosphorylation state of eucaryotic initiation factor 2 alters translational efficiency of specific mRNAs.

Authors:  R J Kaufman; M V Davies; V K Pathak; J W Hershey
Journal:  Mol Cell Biol       Date:  1989-03       Impact factor: 4.272

2.  Translation by the adenovirus tripartite leader: elements which determine independence from cap-binding protein complex.

Authors:  P J Dolph; J T Huang; R J Schneider
Journal:  J Virol       Date:  1990-06       Impact factor: 5.103

3.  Enhanced malignant transformation induced by expression of a distinct protein domain of ribonucleotide reductase large subunit from herpes simplex virus type 2.

Authors:  M A Ali; D McWeeney; A Milosavljevic; J Jurka; R J Jariwalla
Journal:  Proc Natl Acad Sci U S A       Date:  1991-09-15       Impact factor: 11.205

4.  The adenovirus type 5 i-leader open reading frame functions in cis to reduce the half-life of L1 mRNAs.

Authors:  P D Soloway; T Shenk
Journal:  J Virol       Date:  1990-02       Impact factor: 5.103

Review 5.  Large-scale transfection of mammalian cells for the fast production of recombinant protein.

Authors:  Phuong Lan Pham; Amine Kamen; Yves Durocher
Journal:  Mol Biotechnol       Date:  2006-10       Impact factor: 2.695

6.  The tripartite leader sequence of subgroup C adenovirus major late mRNAs can increase the efficiency of mRNA export.

Authors:  W Huang; S J Flint
Journal:  J Virol       Date:  1998-01       Impact factor: 5.103

7.  A model for the initiation of translation at the late stage after infection by adenoviruses.

Authors:  A Murasugi
Journal:  Biochem J       Date:  1989-06-01       Impact factor: 3.857

8.  cis-acting elements and a trans-acting factor affecting alternative splicing of adenovirus L1 transcripts.

Authors:  C Delsert; N Morin; D F Klessig
Journal:  Mol Cell Biol       Date:  1989-10       Impact factor: 4.272

9.  RNA-binding properties of a translational activator, the adenovirus L4 100-kilodalton protein.

Authors:  D Riley; S J Flint
Journal:  J Virol       Date:  1993-06       Impact factor: 5.103

10.  mRNA export correlates with activation of transcription in human subgroup C adenovirus-infected cells.

Authors:  U C Yang; W Huang; S J Flint
Journal:  J Virol       Date:  1996-06       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.